Canon Medical has released these two resource documents "Lung Ultrasound for COVID-19" and "Cardiac Ultrasound for COVID-19" as a response to the World Health Organization's recent guidance that suggests that chest imaging, including lung and cardiac ultrasound, may be helpful for management of COVID-19 patients.
Both documents provide clinical examples, specific protocols and recommended settings for how to use Canon Medical's ultrasound product line effectively for each procedure.
Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment.
Canon Medical Systems Corp. develops and manufactures diagnostic imaging systems including CT, MRI, ultrasound, X-ray systems and clinical laboratory systems and provides them to around 140 countries and regions around the world, offering technology that provides faster diagnosis and early treatment.
CSL reveals top-line outcome from Phase three AEGIS-II trial of CSL112
AstraZeneca invests USD300m to expand US manufacturing for cell therapy
Innovent Biologics announces CFO transition
Cardio Diagnostics appoints Dr Vimal Ramjee as Strategic Advisor
Acticor Biotech reports positive ACTIMIS clinical study results in Lancet Neurology Journal
Sarepta Therapeutics commences Phase 3 clinical study of SRP-9003 for LGMD2E